Literature DB >> 1920731

Macular degeneration: is aspirin a risk for progressive disease?

M L Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1920731     DOI： 10.1001/jama.266.16.2279b

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women.

Authors:  William G Christen; Robert J Glynn; Emily Y Chew; Julie E Buring
Journal:  Ophthalmology       Date:  2009-10-07       Impact factor: 12.079

2.  Association between Antiplatelet or Anticoagulant Drugs and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Authors:  Gui-Shuang Ying; Maureen G Maguire; Ebenezer Daniel; Juan E Grunwald; Osama Ahmed; Daniel F Martin
Journal:  Ophthalmology       Date:  2015-11-04       Impact factor: 12.079

Review 3.  Aspirin and age related macular degeneration; the possible relationship.

Authors:  Yan Wu; Wei Zhu; Yan-Hong Li; Jing Yu
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2013

4.  Aspirin use and risk of age-related macular degeneration: a meta-analysis.

Authors:  Wei Zhu; Yan Wu; Ding Xu; Yan-Hong Li; Ba Jun; Xiao-Long Zhang; Fang Wang; Jing Yu
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

5.  Incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation.

Authors:  Jae Hyung Lee; Mee Yon Lee; Won Ki Lee
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.